2014 Hope Gala Sponsors

  • Allscripts
  • Alphanumeric Systems Inc.
  • BD Technologies
  • Novo Nordisk Pharmaceutical Industries
  • Mr. & Mrs. Michael & Eileen Hendren
  • Horne Brothers Construction
  • Salix Pharmaceuticals
  • Batchelor, Tillery & Roberts, LLP
  • Mr. Damon & Mrs. Melissa Blaco
  • BlueCross BlueShield of North Carolina
  • Mr. Larry Mackell & Ms. Darleen Johns
  • Moffat Pipe, Inc.
  • NC Retina
  • Qlik
  • UNC / REX healthcare
  • UNC Health Care
  • Wells Fargo Company
  • Wyrick Robbins Yates & Ponton, LLP
  • Deloitte Tax LLP
  • First Citizens Bank
  • Mr. Uzal & Jun Martz
  • Mr. Daniel & Mrs. Janice Norman
  • Coastal Federal Credit Union
  • Mr. David & Kelly Greenlee
  • Rex Healthcare
  • Sibson Consulting
  • WakeMed
  • Whitlock IT
  • Burt's Bees
  • Eagle Rock Concrete
  • Medtronic
  • Professional Builders Supply
  • Red Hat Inc.
  • RGA Investments
  • Duke Energy
  • Johnson Lexus
  • MMI Public Relations
  • Mr. & Mrs. Chris & Lisa LaTurno
  • Mr. & Mrs. Don & Barbara Curtis
 
Members of our chapter can help accelerate the pace of type 1 diabetes (T1D) research by partnering with JDRF to raise funds for the annual Gala Fund A Cure campaign. All you have to do is set up a fundraising page, email the link to your peers, and ask them to support T1D research! To get started, please sign up here.

Click here to join!

JDRF is the leading global organization funding type 1 diabetes (T1D) research. Type 1 diabetes is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone that enables people to get energy from food. JDRF's goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and working plan to better treat, prevent, and eventually cure T1D.

As the largest charitable supporter of T1D research, JDRF is currently sponsoring $530 million in scientific research in 17 countries. In 2012 alone, JDRF provided more than $110 million to T1D research. More than 80 percent of JDRF's expenditures directly support research and research-related education. In 2012, Forbes magazine named JDRF one of its five All-Star charities, citing the organization’s efficiency and effectiveness.